Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
0.762
-0.025 (-3.21%)
At close: Apr 28, 2026, 4:00 PM EDT
0.783
+0.021 (2.81%)
After-hours: Apr 28, 2026, 7:29 PM EDT
Tenon Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 3.94 | 3.28 | 2.93 | 0.69 | 0.16 | |
| Revenue Growth (YoY) | 20.35% | 11.92% | 323.73% | 331.88% | 265.13% | |
| Cost of Revenue | 1.59 | 1.57 | 1.69 | 1.33 | 0.06 | |
| Gross Profit | 2.36 | 1.71 | 1.24 | -0.64 | 0.11 | |
| Selling, General & Admin | 12.22 | 12.87 | 13.81 | 14.68 | 4.85 | |
| Research & Development | 2.15 | 2.6 | 3.16 | 2.83 | 1.72 | |
| Operating Expenses | 14.37 | 15.48 | 16.97 | 17.51 | 6.57 | |
| Operating Income | -12.01 | -13.77 | -15.73 | -18.15 | -6.46 | |
| Interest Expense | - | -0.03 | -0.02 | -0.35 | -0.62 | |
| Interest & Investment Income | 0.24 | 0.18 | 0.17 | 0.18 | 0 | |
| Other Non Operating Income (Expenses) | - | -0.06 | - | -0.02 | -0 | |
| EBT Excluding Unusual Items | -11.78 | -13.67 | -15.58 | -18.34 | -7.08 | |
| Merger & Restructuring Charges | -0.78 | - | - | - | - | |
| Legal Settlements | - | - | - | -0.57 | - | |
| Pretax Income | -12.56 | -13.67 | -15.58 | -18.92 | -7.08 | |
| Earnings From Continuing Operations | -12.56 | -13.67 | -15.58 | -18.92 | -7.08 | |
| Minority Interest in Earnings | - | - | - | - | 0.03 | |
| Net Income | -12.56 | -13.67 | -15.58 | -18.92 | -7.05 | |
| Net Income to Common | -12.56 | -13.67 | -15.58 | -18.92 | -7.05 | |
| Shares Outstanding (Basic) | 7 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 7 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 508.24% | 434.80% | 124.75% | 794.75% | 8.80% | |
| EPS (Basic) | -1.70 | -11.26 | -68.64 | -187.30 | -624.38 | |
| EPS (Diluted) | -1.70 | -11.26 | -68.64 | -187.30 | -624.38 | |
| Free Cash Flow | -11.77 | -10.06 | -12.54 | -12.87 | -4.39 | |
| Free Cash Flow Per Share | -1.59 | -8.29 | -55.26 | -127.45 | -389.26 | |
| Gross Margin | 59.79% | 52.21% | 42.38% | -92.76% | 65.63% | |
| Operating Margin | -304.59% | -420.08% | -537.12% | -2626.77% | -4038.13% | |
| Profit Margin | -318.36% | -417.24% | -532.14% | -2737.63% | -4405.00% | |
| Free Cash Flow Margin | -298.38% | -307.11% | -428.42% | -1862.81% | -2746.25% | |
| EBITDA | -11.76 | -13.36 | -15.53 | -18.07 | -6.46 | |
| EBITDA Margin | -298.07% | - | - | - | - | |
| D&A For EBITDA | 0.26 | 0.41 | 0.2 | 0.08 | 0 | |
| EBIT | -12.01 | -13.77 | -15.73 | -18.15 | -6.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.